Inhibikase Therapeutics, Inc.
IKT
Revenue
0.00
0.000.00%
3 Months ChangeAssets
79.59M
▼-9.26M▼-10.42%
3 Months ChangeLiabilities
6.70M
▼-2.10M▼-23.90%
3 Months ChangeFree Cash Flow
-4.12M
▼-249.91k▼-6.46%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2025-12-19
Form 8-K
ID: 0001193125-25-326916
2025-11-21
Form 8-K
ID: 0001193125-25-291443
2025-11-20
Form 8-K
ID: 0001193125-25-289768
2025-11-14
Form 10-Q
ID: 0001193125-25-283169
2025-11-14
Form 8-K
ID: 0001193125-25-283075
2025-08-14
Form 10-Q
ID: 0001193125-25-180899
2025-08-14
Form 8-K
ID: 0001193125-25-180889
2025-06-30
Form 8-K
ID: 0001193125-25-152767
2025-05-14
Form 10-Q
ID: 0000950170-25-071635
2025-05-14
Form 8-K
ID: 0001193125-25-119939